의약품 ADMET 시험 시장 : 기회 및 전략(-2035년)

Pharma ADMET testing refers to a group of laboratory and computational processes used in the pharmaceutical industry to evaluate the absorption, distribution, metabolism, excretion and toxicity (ADMET) profiles of drug candidates. It is an essential component of the drug discovery and development process, allowing researchers and developers to assess how a new compound behaves in the body and its potential safety risks before proceeding to clinical trials.

The pharma ADMET testing market consists of sales, by entities (organizations, sole traders, or partnerships) is used by pharmaceutical companies, biotechnology firms, contract research organizations (CROs) and academic research institutions. The testing is conducted at early and preclinical stages of drug development and continues through the early phases of clinical trials to eliminate compounds with unfavorable pharmacokinetic or toxicity profiles.

The global pharma ADMET testing market was valued at $6,062.9 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 11.0%.

Rising Pharma-Related R&D Spending

During the historic period, the pharma ADMET testing market was driven by rising pharma-related R&D spending. Increasing funding toward drug discovery and development resulted in a greater number of compounds entering early-stage screening, thereby intensifying the need for comprehensive ADME and toxicology evaluation. This rise in investment supported deeper scientific exploration, accelerated development cycles and encouraged pharmaceutical companies to expand their research portfolios. For instance, in December 2024, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a global industry body representing research-based biopharmaceutical companies, published its Always Innovating: Facts & Figures report, highlighting that the top 50 pharmaceutical companies invested USD 167 billion in R&D in 2022, marking a 60% increase compared with 2012. The report emphasized the sector's commitment to scientific advancement, strengthened innovation capacity and expansion of research pipelines across the world. Therefore, the pharma ADMET testing market was driven by rising pharma-related R&D spending.

Establishment Of Dedicated Peptide Laboratories To Support Pharma ADMET Testing

Major companies in the pharma ADMET testing market are focusing on the establishment of dedicated peptide laboratories designed to support the growing demand for peptide-based therapeutics and streamline ADMET and preclinical workflows. These developments emphasize enhanced peptide synthesis capacity, automation-driven throughput, and integrated purification and quality-control processes to meet rising requirements for high-quality, scalable testing inputs. For instance, in October 2025, Syngene International, an India-based contract research, development and manufacturing organization, launched a state-of-the-art peptide laboratory and advanced automation systems in its DMPK and Direct-to-Biology operations, aimed at improving efficiency, consistency, and scalability for ADMET testing and drug-discovery support. By leveraging modern automation technologies and specialized peptide infrastructure, the company aims to deliver a more efficient, reliable and scalable solution, enabling faster, more robust ADMET testing services to meet evolving needs in both domestic and global pharmaceutical markets.

The global pharma ADMET testing market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 11.92% of the total market in 2024.

Pharma ADMET Testing Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharma ADMET testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for pharma ADMET testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharma ADMET testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pharma ADMET testing market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by testing type, by technology, and by application.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by testing type, by technology, and by application in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for Pharma ADMET testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing
• 2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology
• 3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications
• Companies Mentioned: Thermo Fisher Scientific Inc. (PPD ICON plc); IQVIA Inc.; Charles River Laboratories International Inc.; Laboratory Corporation of America Holdings (Covance Inc.); Eurofins Scientific SE
• Countries: China; India; USA; South Korea; Japan; Brazil; Indonesia; Germany; UK; Russia; France; Italy; Canada; Spain; Australia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharma ADMET testing indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Pharma ADMET Testing - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Pharma ADMET Testing Market Definition And Segmentations
• 6.4 Market Segmentation By Testing Type
  • 6.4.1 In Vivo ADMET Testing
  • 6.4.2 In Vitro ADMET Testing
  • 6.4.3 In Silico ADMET Testing
• 6.5 Market Segmentation By Technology
  • 6.5.1 Cell Culture
  • 6.5.2 High Throughput
  • 6.5.3 Molecular Imaging
  • 6.5.4 OMICS Technology
• 6.6 Market Segmentation By Application
  • 6.6.1 Systemic Toxicity
  • 6.6.2 Renal Toxicity
  • 6.6.3 Hepatotoxicity
  • 6.6.4 Neurotoxicity
  • 6.6.5 Other Applications

7 Major Market Trends

• 7.1 Establishment Of Dedicated Peptide Laboratories To Support Pharma ADMET Testing
• 7.2 Expansion Of DMPK Infrastructure To Strengthen Large-Scale ADMET Testing Capabilities
• 7.3 Adoption Of Digital Platforms To Streamline DMPK And ADMET Testing Workflows
• 7.4 Launch Of Online Ordering Platforms To Improve Access To ADMET Testing Services
• 7.5 Adoption Of Automated Analytical Workflows To Improve Medicinal Chemistry And ADMET Testing Efficiency

8 Pharma ADMET Testing Growth Analysis And Strategic Analysis Framework

• 8.1 Global Pharma ADMET Testing PESTEL Analysis
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End User (B2B)
  • 8.2.1 Pharmaceutical companies
  • 8.2.2 Biotechnology companies
  • 8.2.3 Contract Research Organizations (CROs)
  • 8.2.4 Academic And Research Institutes
• 8.3 Global Pharma ADMET Testing Market Growth Rate Analysis
• 8.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 8.4.1 Market Drivers 2020 - 2025
  • 8.4.2 Market Restraints 2020 - 2025
• 8.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Total Addressable Market for the Pharma ADMET Testing Market - Business to Customer (B2C)
  • 8.7.1 TAM Comparison Analysis

9 Global Pharma ADMET Testing Market Segmentation

• 9.1 Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.2 Global Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.3 Global Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.4 Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.5 Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.6 Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

10 Pharma ADMET Testing Market, Regional and Country Analysis

• 10.1 Global Pharma ADMET Testing Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 10.2 Global Pharma ADMET Testing Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia-Pacific Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.4 Asia-Pacific Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.5 Asia-Pacific Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.6 Asia-Pacific Pharma ADMET Testing Market: Country Analysis
• 11.7 China Market
• 11.8 Summary
• 11.9 Market Overview
  • 11.9.1 Country Information
  • 11.9.2 Market Information
  • 11.9.3 Background Information
  • 11.9.4 Government Initiatives
  • 11.9.5 Regulations
  • 11.9.6 Regulatory Bodies
  • 11.9.7 Major Associations
  • 11.9.8 Taxes Levied
  • 11.9.9 Corporate Tax Structure
  • 11.9.10 Investments
  • 11.9.11 Major Companies
• 11.10 China Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.11 China Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.12 China Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.13 India Market
• 11.14 India Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.15 India Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.16 India Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.17 Japan Market
• 11.18 Summary
• 11.19 Market Overview
  • 11.19.1 Country Information
  • 11.19.2 Market Information
  • 11.19.3 Background Information
  • 11.19.4 Government Initiatives
  • 11.19.5 Regulations
  • 11.19.6 Regulatory Bodies
  • 11.19.7 Major Associations
  • 11.19.8 Taxes Levied
  • 11.19.9 Corporate Tax Structure
  • 11.19.10 Investments
  • 11.19.11 Major Companies
• 11.20 Japan Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.21 Japan Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.22 Japan Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.23 South Korea Market
• 11.24 Summary
• 11.25 Market Overview
  • 11.25.1 Country Information
  • 11.25.2 Market Information
  • 11.25.3 Background Information
  • 11.25.4 Government Initiatives
  • 11.25.5 Regulations
  • 11.25.6 Regulatory Bodies
  • 11.25.7 Major Associations
  • 11.25.8 Taxes Levied
  • 11.25.9 Corporate Tax Structure
  • 11.25.10 Investments
  • 11.25.11 Major Companies
• 11.26 South Korea Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.27 South Korea Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.28 South Korea Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.29 Australia Market
• 11.30 Australia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.31 Australia Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.32 Australia Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.33 Indonesia Market
• 11.34 Indonesia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.35 Indonesia Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.36 Indonesia Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Western Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.4 Western Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.5 Western Europe Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.6 UK Market
• 12.7 UK Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.8 UK Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.9 UK Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.10 Germany Market
• 12.11 Germany Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.12 Germany Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.13 Germany Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.14 France Market
• 12.15 France Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.16 France Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.17 France Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.18 Italy Market
• 12.19 Italy Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.20 Italy Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.21 Italy Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.22 Spain Market
• 12.23 Spain Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.24 Spain Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.25 Spain Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Eastern Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.4 Eastern Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.5 Eastern Europe Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.6 Eastern Europe Pharma ADMET Testing Market: Country Analysis
• 13.7 Russia Market
• 13.8 Russia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.9 Russia Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.10 Russia Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.4 North America Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.5 North America Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.6 North America Pharma ADMET Testing Market: Country Analysis
• 14.7 USA Market
• 14.8 Summary
• 14.9 Market Overview
  • 14.9.1 Country Information
  • 14.9.2 Market Information
  • 14.9.3 Background Information
  • 14.9.4 Government Initiatives
  • 14.9.5 Regulations
  • 14.9.6 Regulatory Bodies
  • 14.9.7 Major Associations
  • 14.9.8 Taxes Levied
  • 14.9.9 Corporate Tax Structure
  • 14.9.10 Investments
  • 14.9.11 Major Companies
• 14.10 USA Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.11 USA Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.12 USA Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.13 Canada Market
• 14.14 Summary
• 14.15 Market Overview
  • 14.15.1 Country Information
  • 14.15.2 Market Information
  • 14.15.3 Background Information
  • 14.15.4 Government Initiatives
  • 14.15.5 Regulations
  • 14.15.6 Regulatory Bodies
  • 14.15.7 Major Associations
  • 14.15.8 Taxes Levied
  • 14.15.9 Corporate Tax Structure
  • 14.15.10 Major Companies
• 14.16 Canada Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.17 Canada Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.18 Canada Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Major Companies
• 15.3 South America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 South America Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.5 South America Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.6 South America Pharma ADMET Testing Market: Country Analysis
• 15.7 Brazil Market
• 15.8 Brazil Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.9 Brazil Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.10 Brazil Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Major Companies
• 16.3 Middle East Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Middle East Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Middle East Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Major Companies
• 17.3 Africa Pharma ADMET Testing Market, Segmentation By Testing Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Africa Pharma ADMET Testing Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Africa Pharma ADMET Testing Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Thermo Fisher Scientific Inc. (PPD ICON plc)
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Financial Overview
• 18.3 IQVIA Inc
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Financial Overview
• 18.4 Charles River Laboratories International Inc
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Business Strategy
  • 18.4.4 Financial Overview
• 18.5 Laboratory Corporation of America Holdings (Covance Inc.)
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Business Strategy
  • 18.5.4 Financial Overview
• 18.6 Eurofins Scientific SE
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Financial Overview

19 Other Major And Innovative Companies

• 19.1 WuXi AppTec Co. Ltd.
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 Agilent Technologies Inc.
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 PerkinElmer Inc.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 Evotec A.G. (including Aptuit LLC, Cyprotex Limited)
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Catalent Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
• 19.6 Parexel
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
• 19.7 The Merck Group (Merck KGaA)
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
• 19.8 Beckman Coulter Inc.
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
• 19.9 Pharmaron Beijing Co. Ltd.
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
• 19.10 SRI International
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
• 19.11 Piramal Pharma Solutions
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
• 19.12 CMIC Holdings Co. Ltd.
  • 19.12.1 Company Overview
  • 19.12.2 Products And Services
• 19.13 RTI International
  • 19.13.1 Company Overview
  • 19.13.2 Products And Services
• 19.14 Promega Corporation
  • 19.14.1 Company Overview
  • 19.14.2 Products And Services
• 19.15 BioIVT LLC
  • 19.15.1 Company Overview
  • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Scantox Group Acquired Gentronix Ltd
• 22.2 BioIVT Acquired ZenBio Inc.
• 22.3 BioIVT Acquired XenoTech

23 Recent Developments In Pharma ADMET Testing

• 23.1 AI-Powered PGP Substrate Prediction Advances Early Drug-Discovery Screening
• 23.2 ADMET Predictor 13 Launched With Enhanced AI and HT-PBPK Capabilities

24 Opportunities And Strategies

• 24.1 Global Pharma ADMET Testing Market In 2030 - Countries Offering Most New Opportunities
• 24.2 Global Pharma ADMET Testing Market In 2030 - Segments Offering Most New Opportunities
• 24.3 Global Pharma ADMET Testing Market In 2030 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Pharma ADMET Testing Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer